Crossmark

Implications of liver fibrosis in clinical trials

Crossref DOI link: https://doi.org/10.1016/j.aohep.2025.102112

Published Print: 2025-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Jahagirdar, Vinay https://orcid.org/0000-0001-6685-1033
Rama, Kaanthi https://orcid.org/0000-0002-1691-7812
Cabrera, Daniel https://orcid.org/0000-0001-9634-725X
Idalsoaga, Francisco https://orcid.org/0000-0001-5607-0698
Díaz, Luis Antonio https://orcid.org/0000-0002-8540-4930
Arrese, Marco https://orcid.org/0000-0002-0499-4191
Arab, Juan Pablo https://orcid.org/0000-0002-8561-396X
License Information

Text and Data Mining valid from 2025-07-01

Text and Data Mining valid from 2025-07-01

Version of Record valid from 2025-09-05
More Information

This article is maintained by: Elsevier

Article Title: Implications of liver fibrosis in clinical trials

Journal Title: Annals of Hepatology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.aohep.2025.102112

Content Type: simple-article

Copyright: © 2025 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U.